Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS

Pathobiology

Volumn 74, Issue 2, 2007, Pages 115-120

  Dirnhofer, Stephan ^a   Went, Philip ^a   Tichelli, André ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Acute leukemia; Bone marrow biopsy; Chronic leukemia; MDS; Post therapy changes

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; B LYMPHOCYTE; BLOOD FLOW; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CELL COUNT; CEREBROSPINAL FLUID; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MYELODYSPLASIA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PATHOLOGIST; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TREATMENT OUTCOME;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; BIOPSY; BONE MARROW; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; TREATMENT OUTCOME;

EID: 34250848297     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101710     Document Type: Review

References (11)

1. Foucar K: Interpretation of postchemotherapy and posttransplantation bone marrow specimens; in Knowles DM (ed): Neoplastic Hematopathology. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 1791-1814.
2. Orazi A, O'Malley D, Arber DA: Illustrated Pathology of the Bone Marrow. Cambridge, Cambridge University Press, 2006.
3. Rimsza LM, Larson RS, Winter SS, Foucar K, Chong YY, Garner KW, Leith CP: Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features. Am J Clin Pathol 2000;114:66-75.
4. Hurwitz N: Bone marrow trephine biopsy changes following chemotherapy and/or bone marrow transplantation. Curr Diagn Pathol 1997;4:196-202.
5. Foucar K: Bone Marrow Pathology. Chicago, ASCP Press, 2001.
6. Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, Estey EH, Schiffer CA, Doehner H, Tallman MS, Lister TA, LoCoco F, Willemze R, Biondi A, Hiddemann W, Larson RA, Lowenberg B, Sanz MA, Head DR, Ohno R, Bloomfield CD: Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003;21:4642-4649.
7. De Greef GE, van Putten WL, Boogaerts M, Huijgens PC, Verdonck LF, Vellenga E, Theobald M, Jacky E, Lowenberg B: Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studies. Br J Haematol 2005;128:184-191.
8. Rimsza LM, Viswanatha DS, Winter SS, Leith CP, Frost JD, Foucar K: The presence of CD34+ cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy. Am J Clin Pathol 1998;110:313-320.
9. Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, Apperley J, Cervantes F, Cortes J, Deininger M, Gratwohl A, Guilhot F, Horowitz M, Hughes T, Kantarjian H, Larson R, Niederwieser D, Silver R, Hehlmann R; European LeukemiaNet: Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2006;108:1809-1820.
10. Lugli A, Ebnoether M, Cogliatti SB, Gratwohl A, Passweg J, Hess U, Korte W, Hawle H, Tinguely M, Borisch B, Mach-Pascual S, Von Juergensonn S, Tichelli A, Dirnhofer S: Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia. Hum Pathol 2005;36:91-100.
11. Cheson BD, Bennett JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD, Lowenberg B, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Wijermans PW, Gore S, Greenberg PL: Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood 2000;96:3671-3674.